• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

并非所有胎儿游离 DNA 筛查失败的低分数都有较高的非整倍体风险。

Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.

机构信息

Women's Health and Genetics, Laboratory Corporation of America, La Jolla, California, USA.

Augustana University, Sioux Falls, South Dakota, USA.

出版信息

Prenat Diagn. 2021 Oct;41(11):1372-1379. doi: 10.1002/pd.5918. Epub 2021 Mar 8.

DOI:10.1002/pd.5918
PMID:33682142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8596865/
Abstract

OBJECTIVE

To evaluate cell-free DNA (cfDNA) redraws and pregnancy outcomes following low fetal fraction (FF) cfDNA failures, as it has been suggested that a failed cfDNA screen due to insufficient FF carries increased risk for fetal aneuploidy.

METHODS

Here >200,000 consecutive samples were reviewed and >1,100 patients were identified with a failed cfDNA due to low FF using genome-wide massively parallel sequencing. Redraw results following the initial low FF failure were analyzed, as well as pregnancy outcomes for patients with repeated low FF failure on redraw.

RESULTS

Upon redraw 84.2% of samples yielded a reportable result with no enrichment of aneuploidy observed (p = 0.332). Higher maternal weights and multifetal pregnancy rates were observed in samples with insufficient FF. In patients with repeated low FF failure on redraw, almost all pregnancies resulted in apparently healthy liveborns.

CONCLUSION

Insufficient FF was not an indicator of aneuploidy risk or adverse pregnancy outcomes in this study. Caution should be taken in generalizing aneuploidy risk to all low FF cfDNA failures. Redrawing may be an appropriate next step, as proceeding directly with diagnostic testing for aneuploidy may be unwarranted for most patients.

摘要

目的

评估由于胎儿游离 DNA(cfDNA)片段含量低而导致 cfDNA 检测失败后的游离 DNA 重抽结果和妊娠结局,因为有研究表明,由于 cfDNA 片段含量低而导致 cfDNA 筛查失败可能会增加胎儿非整倍体的风险。

方法

对超过 20 万例连续样本进行了回顾性分析,发现有 1100 多例患者由于 cfDNA 片段含量低而导致 cfDNA 检测失败。分析了初始 cfDNA 片段含量低而导致检测失败后的游离 DNA 重抽结果,以及在重抽时多次出现 cfDNA 片段含量低而导致检测失败的患者的妊娠结局。

结果

在游离 DNA 重抽时,84.2%的样本得出了可报告的结果,未观察到非整倍体的富集(p=0.332)。在 cfDNA 片段含量低的样本中,母亲体重较高和多胎妊娠率较高。在重复 cfDNA 片段含量低而导致检测失败的患者中,几乎所有的妊娠都导致了明显健康的活产儿。

结论

在本研究中,cfDNA 片段含量低并不是非整倍体风险或不良妊娠结局的指标。在一般情况下,cfDNA 片段含量低的所有 cfDNA 检测失败都不能被认为是非整倍体风险高。重抽可能是一个合适的下一步,因为对于大多数患者来说,直接进行非整倍体的诊断性检测可能是不必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/040e82cc6599/PD-41-1372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/32a9e2cd1237/PD-41-1372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/acf89d0ce425/PD-41-1372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/040e82cc6599/PD-41-1372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/32a9e2cd1237/PD-41-1372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/acf89d0ce425/PD-41-1372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7008/8596865/040e82cc6599/PD-41-1372-g001.jpg

相似文献

1
Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.并非所有胎儿游离 DNA 筛查失败的低分数都有较高的非整倍体风险。
Prenat Diagn. 2021 Oct;41(11):1372-1379. doi: 10.1002/pd.5918. Epub 2021 Mar 8.
2
Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.爱尔兰游离胎儿 DNA 筛查用于胎儿非整倍体检测:胎儿细胞浓度不足的检测结果观察性研究。
Eur J Obstet Gynecol Reprod Biol. 2023 Nov;290:143-149. doi: 10.1016/j.ejogrb.2023.09.023. Epub 2023 Sep 27.
3
Obesity and no call results: optimal timing of cell-free DNA testing and redraw.肥胖与无结果召回:游离 DNA 检测和重抽的最佳时机
Am J Obstet Gynecol. 2021 Oct;225(4):417.e1-417.e10. doi: 10.1016/j.ajog.2021.04.212. Epub 2021 Apr 8.
4
Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.短 cfDNA 片段测序可提高无创产前检测中胎儿 DNA 比例。
Am J Obstet Gynecol. 2019 Oct;221(4):345.e1-345.e11. doi: 10.1016/j.ajog.2019.05.023. Epub 2019 May 21.
5
Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.将基于胎儿比例的风险算法与非侵入性产前检测中信息丰富的重新检测概率相结合,用于胎儿非整倍体检测。
J Genet Couns. 2020 Oct;29(5):800-806. doi: 10.1002/jgc4.1208. Epub 2019 Dec 23.
6
Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.母体血浆游离基因组 DNA 可检测早发性和复发性妊娠丢失胎儿的非整倍体,并可用于指导进一步的检查。
Hum Reprod. 2020 May 1;35(5):1222-1229. doi: 10.1093/humrep/deaa073.
7
A fetal fraction enrichment method reduces false negatives and increases test success rate of fetal chromosome aneuploidy detection in early pregnancy loss.一种胎儿分数富集方法可降低假阴性率,提高早孕期流产胎儿染色体非整倍体检测的试验成功率。
J Transl Med. 2022 Aug 2;20(1):345. doi: 10.1186/s12967-022-03555-9.
8
Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk.高体重指数患者的无创性产前筛查:评估定制全基因组测序工作流程对灵敏度和剩余风险的影响。
Prenat Diagn. 2020 Feb;40(3):333-341. doi: 10.1002/pd.5603. Epub 2019 Dec 20.
9
Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.大多数因胎儿游离DNA不足而失败的无创产前筛查在重复检测时三体结果为阴性。
Prenat Diagn. 2020 Jun;40(7):831-837. doi: 10.1002/pd.5693. Epub 2020 Apr 20.
10
High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes.孕早期游离DNA非整倍体筛查中高胎儿分数与不良妊娠结局
Am J Perinatol. 2020 Jan;37(1):8-13. doi: 10.1055/s-0039-1694005. Epub 2019 Jul 31.

引用本文的文献

1
Cell-Free Fetal DNA Screening Analysis in Korean Pregnant Women: Six Years of Experience and a Retrospective Study of 9327 Patients Analyzed from 2017 to 2022.韩国孕妇的游离胎儿DNA筛查分析:六年经验及对2017年至2022年分析的9327例患者的回顾性研究
J Pers Med. 2023 Oct 6;13(10):1468. doi: 10.3390/jpm13101468.

本文引用的文献

1
Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.大多数因胎儿游离DNA不足而失败的无创产前筛查在重复检测时三体结果为阴性。
Prenat Diagn. 2020 Jun;40(7):831-837. doi: 10.1002/pd.5693. Epub 2020 Apr 20.
2
A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory.在非整倍体筛查的新时代:30,000 余例多胎妊娠中的 cfDNA 检测:一个临床实验室的经验。
PLoS One. 2019 Aug 8;14(8):e0220979. doi: 10.1371/journal.pone.0220979. eCollection 2019.
3
Influence of Body Mass Index on Fetal Fraction Increase With Gestation and Cell-Free DNA Test Failure.
体重指数对胎儿分数随妊娠增加的影响和游离 DNA 测试失败。
Obstet Gynecol. 2018 Aug;132(2):436-443. doi: 10.1097/AOG.0000000000002752.
4
Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing.与初始非侵入性产前检测无结果后进行信息性重抽相关的因素。
Obstet Gynecol. 2018 Aug;132(2):428-435. doi: 10.1097/AOG.0000000000002728.
5
Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.低胎儿游离DNA比例下的无创产前筛查:全基因组测序与单核苷酸多态性方法的比较
Prenat Diagn. 2017 May;37(5):482-490. doi: 10.1002/pd.5036. Epub 2017 Apr 26.
6
Obesity and cell-free DNA "no calls": is there an optimal gestational age at time of sampling?肥胖与游离DNA“无检出”:采样时是否存在最佳孕周?
Am J Obstet Gynecol. 2017 Apr;216(4):413.e1-413.e9. doi: 10.1016/j.ajog.2017.01.011. Epub 2017 Jan 30.
7
Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health.使用游离DNA进行非整倍体的无创产前检测——对孕产妇健康的新意义。
Obstet Med. 2016 Dec;9(4):148-152. doi: 10.1177/1753495X16652007. Epub 2016 Jun 7.
8
Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.胎儿非整倍体无创产前筛查,2016年更新:美国医学遗传学与基因组学学会立场声明
Genet Med. 2016 Oct;18(10):1056-65. doi: 10.1038/gim.2016.97. Epub 2016 Jul 28.
9
Obesity increases the risk of failure of noninvasive prenatal screening regardless of gestational age.肥胖症增加了非侵入性产前筛查失败的风险,无论孕龄如何。
Am J Obstet Gynecol. 2016 Sep;215(3):370.e1-6. doi: 10.1016/j.ajog.2016.03.018. Epub 2016 Mar 17.
10
Practice Bulletin No. 163: Screening for Fetal Aneuploidy.实践通报第 163 号:胎儿非整倍体筛查。
Obstet Gynecol. 2016 May;127(5):e123-e137. doi: 10.1097/AOG.0000000000001406.